Literature DB >> 18419745

A new VKORC1 allelic variant (p.Trp59Arg) in a patient with partial resistance to acenocoumarol and phenprocoumon.

E B Wilms, D J Touw, J M H Conemans, R Veldkamp, M Hermans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18419745     DOI： 10.1111/j.1538-7836.2008.02975.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  8 in total

1.  Novel insight into the mechanism of the vitamin K oxidoreductase (VKOR): electron relay through Cys43 and Cys51 reduces VKOR to allow vitamin K reduction and facilitation of vitamin K-dependent protein carboxylation.

Authors:  Mark A Rishavy; Aisulu Usubalieva; Kevin W Hallgren; Kathleen L Berkner
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

2.  A vitamin K epoxide reductase-oxidase complex gene polymorphism (-1639G>A) and interindividual variability in the dose-effect of vitamin K antagonists.

Authors:  E Stepien; A Branicka; M Ciesla-Dul; A Undas
Journal:  J Appl Genet       Date:  2009       Impact factor: 3.240

3.  Absence of novel CYP4F2 and VKORC1 coding region DNA variants in patients requiring high warfarin doses.

Authors:  James K Burmester; Richard L Berg; Ingrid Glurich; Steven H Yale; John R Schmelzer; Michael D Caldwell
Journal:  Clin Med Res       Date:  2011-05-11

Review 4.  Recommendations for Clinical Warfarin Genotyping Allele Selection: A Report of the Association for Molecular Pathology and the College of American Pathologists.

Authors:  Victoria M Pratt; Larisa H Cavallari; Andria L Del Tredici; Houda Hachad; Yuan Ji; Lisa V Kalman; Reynold C Ly; Ann M Moyer; Stuart A Scott; Michelle Whirl-Carrillo; Karen E Weck
Journal:  J Mol Diagn       Date:  2020-05-04       Impact factor: 5.568

5.  A hetero-dimer model for concerted action of vitamin K carboxylase and vitamin K reductase in vitamin K cycle.

Authors:  Sangwook Wu; Shubin Liu; Charles H Davis; Darrel W Stafford; John D Kulman; Lee G Pedersen
Journal:  J Theor Biol       Date:  2011-03-29       Impact factor: 2.691

6.  Evaluation of warfarin resistance using transcription activator-like effector nucleases-mediated vitamin K epoxide reductase knockout HEK293 cells.

Authors:  J-K Tie; D-Y Jin; K Tie; D W Stafford
Journal:  J Thromb Haemost       Date:  2013-08       Impact factor: 5.824

7.  Validation of clinical testing for warfarin sensitivity: comparison of CYP2C9-VKORC1 genotyping assays and warfarin-dosing algorithms.

Authors:  Michael R Langley; Jessica K Booker; James P Evans; Howard L McLeod; Karen E Weck
Journal:  J Mol Diagn       Date:  2009-03-26       Impact factor: 5.568

8.  Adaptative evolution of the Vkorc1 gene in Mus musculus domesticus is influenced by the selective pressure of anticoagulant rodenticides.

Authors:  Joffrey Goulois; Véronique Lambert; Lionel Legros; Etienne Benoit; Virginie Lattard
Journal:  Ecol Evol       Date:  2017-03-21       Impact factor: 2.912
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.